Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24026658 | 0.95 | TDP1 (0.38) | TDP1L3MBTL1ALOX5DUSP3AHR | |
| SCHEMBL24026654 | 0.92 | ALOX5 (0.33) | TDP1L3MBTL1ALOX5AHRALDH1A1 | |
| SCHEMBL24026655 | 0.90 | TDP1 (0.37) | TDP1L3MBTL1ALOX5DUSP3AHR | |
| SCHEMBL21717970 | 0.89 | ALOX5 (0.35) | TDP1L3MBTL1ALOX5DUSP3AHR | |
| SCHEMBL21889620 | 0.89 | ALOX5 (0.38) | L3MBTL1ALOX5AHRALDH1A1NPSR1 | |
| SCHEMBL21717973 | 0.87 | L3MBTL1 (0.43) | TDP1L3MBTL1ALOX5DUSP3AHR | |
| SCHEMBL21717565 | 0.86 | AHR (0.38) | L3MBTL1ALOX5DUSP3AHRALDH1A1 | |
| SCHEMBL24026651 | 0.85 | ALOX5 (0.30) | ALOX5 | |
| SCHEMBL24026646 | 0.85 | — | — | |
| SCHEMBL21717878 | 0.84 | ALOX5 (0.39) | L3MBTL1ALOX5AHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359221-A1 | COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359221-A1 | COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | HAX1, AFF4, XPO4 | TDP1 3487/4885L3MBTL1 2897/4885ALOX5 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.